Home » Topics » Conferences

Conferences
RSS

New raloxifene analogue from Lilly is a potent SERM

Sep. 18, 1997

Novel osteoclast resorption inhibitor isolated by Swiss investigators

Sep. 18, 1997

Known antidiabetic agent modulates glucocorticoid response in osteoclasts

Sep. 18, 1997

3-D database search at Schering-Plough leads to potent, selective FPT inhibitors

Sep. 18, 1997

New anthraquinone interacting with telomeric G-quadruplex DNA

Sep. 18, 1997

Role of osteoprotegerin in skeletal metabolism elucidated

Sep. 18, 1997

Highlights from the Japanese Society of Bone Metabolism Research

Sep. 17, 1997

Potential antipsychotics under development at Taisho/Nihon Nohyaku

Sep. 16, 1997

More on SE-205, a new MMP/TNF inhibitor from DuPont Merck

Sep. 16, 1997

NCI evaluates stability of SarCNU

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...